Professor Ian Davis is a medical oncologist with over 30 years’ experience and primary clinical and research focus in genitourinary cancers. He founded and chairs the ANZUP (Australian and New Zealand Urogenital and Prostate) Cancer Trials Group and is the global co-chair of international ANZUP ENZAMET trial. This trial demonstrated improved survival with enzalutamide for metastatic hormone-sensitive prostate cancer and has led to regulatory approval in US, Europe, Japan, and Australia, leading to multiple awards, including the 2020 Trial of the Year.
Through ANZUP, Professor Davis has established a global genitourinary cancer clinical trials network and mentored many senior clinician-researchers.